Dozens of pills sold over the counter, prescribed by doctors, or marketed as supplements have been linked by rigorous research to organ damage, cancer, stroke, or death under specific circumstances. Some have been pulled from the market entirely. Others remain available but carry risks that most people never read about on the label. What follows are 20 pills that science has flagged as dangerous, whether because of how they are used, who takes them, or what they do to the body at doses people routinely reach.
Painkillers That Can Destroy Your Liver or Heart
Acetaminophen (sold as Tylenol and dozens of store brands) is the single most common cause of acute liver failure in the United States and much of the developed world. At recommended doses it is generally safe, but the margin between a therapeutic dose and a damaging one is narrow. Part of each dose gets converted into a toxic byproduct that the liver normally neutralizes with its own supply of a protective molecule called glutathione. When too much acetaminophen floods the system, that protective supply runs out and the toxic byproduct starts binding directly to liver proteins, triggering a cascade of cell death.1PubMed Central. Clinically relevant therapeutic approaches against acetaminophen hepatotoxicity and acute liver failure Once liver failure sets in, higher doses do not make survival any worse because the damage has already hit a ceiling; the liver is so overwhelmed that additional acetaminophen barely matters.2PubMed Central. Acetaminophen Dose Does Not Predict Outcome in Acetaminophen-Induced Acute Liver Failure The practical takeaway: even modest overdoses, especially combined with alcohol or skipped meals, can push you past the threshold. People who take multiple cold-and-flu products without realizing each one contains acetaminophen are a textbook risk group.
Non-steroidal anti-inflammatory drugs like ibuprofen, naproxen, and diclofenac are household staples for pain and inflammation. Short-term, occasional use is low-risk for most people. Chronic, high-dose use is another story. Heart risk from NSAIDs is now understood to be a class-wide effect, not limited to any single drug, though the size of the risk varies between individual compounds.3PubMed Central. Cardiovascular Risk of Nonsteroidal Anti-Inflammatory Drugs: An Under-Recognized Public Health Issue In long-term clinical trials, chronic high-dose NSAID use has been associated with up to a tripling of cardiovascular risk, though real-world data suggest somewhat lower numbers.4PubMed. Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects For someone who pops ibuprofen daily for months for chronic back pain or arthritis, the cumulative cardiovascular and gastrointestinal toll adds up considerably.
Phenazopyridine, the bright orange pill sold as Pyridium or AZO for urinary tract pain, is intended for very short-term use, typically just two or three days. When taken in excess or for prolonged periods, especially in people with pre-existing kidney problems, it can trigger methemoglobinemia (a condition where the blood loses its ability to carry oxygen), hemolytic anemia, and acute kidney failure.5PubMed. Acute renal failure due to phenazopyridine (Pyridium) overdose: case report and review of the literature Even a single large overdose in someone with normal kidneys has produced severe methemoglobinemia requiring emergency treatment with methylene blue.6JAMA Internal Medicine. Acute Methemoglobinemia and Hemolytic Anemia With Phenazopyridine: Possible Relation to Acute Renal Failure The relief it provides is symptomatic, not curative, so people sometimes keep taking it long after they should have stopped.
Sedatives and Antihistamines That Erode the Brain
Diphenhydramine, the active ingredient in Benadryl and many over-the-counter sleep aids, is one of the most widely used medications in the world. For younger adults taking an occasional dose, risks are modest. For older adults, the picture darkens. In hospitalized older patients, diphenhydramine exposure was tied to a 70% increased risk of cognitive decline compared to unexposed patients. Those who received the drug were also roughly three times more likely to develop inattention and had more than five times the risk of disorganized speech and behavioral disturbance. A dose-response relationship made the connection harder to dismiss: higher doses meant worse cognitive outcomes.7JAMA Internal Medicine. Cognitive and Other Adverse Effects of Diphenhydramine Use in Hospitalized Older Patients Beyond cognition, first-generation antihistamines as a class roughly double the risk of injurious falls or fractures in elderly users, according to a meta-analysis of the available evidence.8PubMed. Antihistamine use and the risk of injurious falls or fracture in elderly patients: a systematic review and meta-analysis Safer alternatives exist for allergies and sleep in older adults, yet diphenhydramine remains the default choice in many medicine cabinets.
Benzodiazepines, the class that includes diazepam (Valium), alprazolam (Xanax), lorazepam (Ativan), and others, are among the most commonly prescribed sedatives worldwide. They work well for short-term management of anxiety, insomnia, and seizures. Long-term use in older adults is where the danger escalates. A meta-analysis pooling ten observational studies found that benzodiazepine users had a significantly increased risk of developing dementia, and that risk was higher in people who took drugs with a longer half-life or who used them for more than three years.9PubMed Central. Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies An umbrella review of multiple meta-analyses confirmed the association, finding elevated dementia risk even after adjusting for conditions like insomnia, anxiety, and depression that might independently contribute to cognitive decline.10PubMed Central. Benzodiazepine Use and the Risk of Dementia in the Elderly Population: An Umbrella Review of Meta-Analyses Whether benzodiazepines cause dementia directly or accelerate an existing trajectory remains debated, but the strength and consistency of the association across studies is enough that most geriatric guidelines now recommend avoiding long-term use in older adults whenever possible.
Weight Loss Pills With Lethal Track Records
The history of weight-loss drugs is littered with products that did exactly what they promised, helping people lose weight, while simultaneously damaging their hearts, brains, or other organs. Several have been pulled from the market; others persist on the black market or in unregulated supplement forms.
Ephedra (also called ma huang) was once the bestselling weight-loss and energy supplement in the United States. Ephedrine, its active compound, is a powerful stimulant. Adverse cardiovascular and cerebrovascular effects including stroke, heart attack, and sudden death were well-documented in people taking ephedra products.11PubMed. Cardiovascular effects of ephedra alkaloids: a comprehensive review One hospital alone evaluated five patients with ischemic strokes tied to over-the-counter ephedra products within a two-year window.12PubMed. Ischemic stroke after using over the counter products containing ephedra The FDA banned ephedra-containing dietary supplements in 2004, but products containing synthetic ephedrine compounds still circulate in some markets.
DNP (2,4-dinitrophenol) is not technically approved for human consumption anywhere, yet it persists as an underground weight-loss drug, primarily in bodybuilding circles. It works by uncoupling the process cells use to generate energy, essentially making the body waste calories as heat. The problem is that this mechanism has no off switch once the drug is in your system. Toxicity produces a terrifying symptom cascade: runaway body temperature, racing heart rate, drenching sweats, and rapid breathing that can progress to death.13PubMed Central. 2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death There is no antidote. Because DNP is sold informally, often as a yellow powder in capsules, dosing is unreliable. Deaths continue to be reported.
Phenylpropanolamine (PPA) was a common ingredient in both over-the-counter diet aids and cold medications for decades. A case-control study linked PPA use in appetite suppressants to hemorrhagic stroke, prompting the FDA to request that all manufacturers remove it from their products.14PubMed. Phenylpropanolamine and stroke: the study, the FDA ruling, the implications A review of stroke cases found PPA-associated strokes at doses ranging from 75 to 675 mg, with intracerebral hemorrhage being the most common type.15PubMed. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs PPA has been off the U.S. market since 2000, but it remains available in some countries.
Sibutramine (sold as Meridia or Reductil) was a prescription weight-loss drug that worked by suppressing appetite through effects on serotonin and norepinephrine. A large trial of overweight and obese patients with cardiovascular risk factors found that sibutramine raised the rate of non-fatal heart attacks by about 28% and non-fatal strokes by about 36% compared to placebo.16PubMed. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects Although sibutramine produced greater weight loss, it increased cardiovascular morbidity without reducing mortality, meaning it made people thinner but sicker.17PubMed. Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial It was withdrawn from the market in 2010. Counterfeit versions still appear in tainted weight-loss supplements sold online.
Yohimbine, derived from the bark of an African tree and marketed for weight loss and sexual performance, is technically legal in the U.S. as a dietary supplement. But a review of California Poison Control System data found that yohimbine exposures caused gastrointestinal distress in nearly half of cases, racing heart in over 40%, anxiety or agitation in a third, and high blood pressure in a quarter. Compared to the average substance exposure reported to the poison control system, yohimbine cases were nearly six times more likely to result in severe outcomes.18PubMed. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases For a supplement that people take casually, that is a troubling safety profile.
Supplements That Increase Cancer Risk
Beta-carotene supplements were once widely promoted as cancer-prevention pills, based on the observation that people who ate lots of beta-carotene-rich vegetables had lower cancer rates. Two landmark trials shattered that assumption. The ATBC trial, involving tens of thousands of male smokers, found that those who received beta-carotene supplements had an 18% higher incidence of lung cancer and 8% higher total mortality than those who did not.19PubMed. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers The CARET trial, which tested the combination of beta-carotene and vitamin A in people at high risk of lung cancer, was halted 21 months early because the supplement group had 28% more lung cancers and 17% more deaths.20JNCI: Journal of the National Cancer Institute. Risk Factors for Lung Cancer and for Intervention Effects in CARET, the Beta-Carotene and Retinol Efficacy Trial Later analysis confirmed that the increased lung cancer risk applied to smokers regardless of the tar or nicotine content of their cigarettes.21PubMed Central. β-Carotene Supplementation and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: The Role of Tar and Nicotine All smokers should avoid beta-carotene supplements. Eating vegetables rich in beta-carotene appears to be a completely different story, likely because of the complex mix of nutrients in whole foods.
High-dose vitamin E supplements were once hoped to prevent prostate cancer. The SELECT trial, a massive study of over 35,000 men, found the opposite: men randomized to receive 400 IU of vitamin E daily had a 17% higher rate of prostate cancer than those on placebo.22JAMA. Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) Laboratory research has since offered a possible mechanism, showing that vitamin E can activate enzymes that convert harmless precursors into carcinogens and promote a pro-oxidant environment that damages DNA and encourages cell transformation.23Scientific Reports. Co-carcinogenic effects of vitamin E in prostate A recent meta-analysis of the broader evidence found no overall benefit of vitamin E for prostate cancer prevention, supporting the conclusion that supplementation is at best useless and at worst actively harmful.24PubMed Central. Vitamin E Intake and Risk of Prostate Cancer: A Meta-Analysis Dietary vitamin E from foods like nuts and seeds does not appear to carry the same risk.
An Herbal Supplement That Harms the Liver
Kava, derived from the root of a Pacific Island plant, has been consumed traditionally for centuries and is marketed as a supplement for anxiety and relaxation. Reports of liver toxicity, including acute hepatitis and liver failure requiring transplantation, prompted several countries (notably Germany and parts of the EU) to ban or restrict kava products. A World Health Organization analysis and subsequent published case reports confirmed that even traditional aqueous extracts can be hepatotoxic, undermining the earlier idea that only modern commercial extraction methods were to blame.25PubMed Central. Kava hepatotoxicity in traditional and modern use: the presumed Pacific kava paradox hypothesis revisited Using structured causality assessment in 14 patients with liver disease worldwide, researchers rated the likelihood that kava caused the damage as highly probable in one case, probable in four, and possible in nine. Risk factors included taking too much, using it for too long, and combining it with other drugs or herbal supplements.26PubMed. Kava hepatotoxicity–a clinical review Part of the problem may trace back to poor-quality raw material contaminated with mould-produced toxins, but this is cold comfort when buyers have no way to test what is in their capsule.27PubMed. Acute hepatitis induced by kava kava
Prescription Drugs Pulled for Heart Risks
Terfenadine (sold as Seldane) was the first non-sedating antihistamine and became enormously popular in the 1980s and 1990s. It was withdrawn from the market after researchers established that it could dangerously prolong the heart’s electrical cycle, a change that can trigger fatal arrhythmias. In patients with cardiovascular disease, terfenadine at standard doses produced average electrical-cycle prolongations of 12 milliseconds, with individual cases reaching 28 milliseconds, and the longest observed intervals crossing into the danger zone above 500 milliseconds.28ScienceDirect (American Heart Journal). Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: Distinguishing a drug effect from spontaneous variability The risk spiked when terfenadine was taken alongside certain other drugs that slowed its breakdown in the liver. Its replacement, fexofenadine (Allegra), provides the same antihistamine benefit without the cardiac effect.
Rosiglitazone (Avandia), once one of the most prescribed diabetes drugs in the world, came under fire when a meta-analysis showed it raised the risk of heart attack by about 43% compared to control treatments.29PubMed. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes A subsequent meta-analysis with longer follow-up confirmed the elevated heart attack risk and found the drug roughly doubled the risk of heart failure.30JAMA. Long-term Risk of Cardiovascular Events With Rosiglitazone: A Meta-analysis Rosiglitazone was not completely banned in the U.S. but had severe prescribing restrictions imposed for years. It remains available in limited circumstances today, though safer diabetes medications have largely replaced it.
A Painkiller Banned for Causing Cancer
Phenacetin was a widely used over-the-counter painkiller throughout the mid-twentieth century, often combined with aspirin and caffeine. It was eventually banned across most of the world after epidemiological evidence showed it caused kidney disease and cancers of the upper urinary tract.31PubMed. The ban on phenacetin is associated with changes in the incidence trends of upper-urinary tract cancers in Australia The cancer risk was dramatic: one study found that regular use of phenacetin-aspirin compounds increased the risk of renal pelvic cancer more than twelvefold.32PubMed. Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis A separate study found that phenacetin use and the kidney tissue damage it caused each independently raised the risk of kidney cancer by roughly three to seven times, and when both were present the risk jumped about twentyfold.33PubMed. Phenacetin and papillary necrosis: independent risk factors for renal pelvic cancer Phenacetin is metabolized in the body to acetaminophen, which replaced it as the safer alternative, though as noted above, acetaminophen brings its own risks at high doses.
Antibiotics With Rare but Serious Consequences
Fluoroquinolones such as ciprofloxacin (Cipro), levofloxacin (Levaquin), and moxifloxacin are powerful antibiotics. They are effective against a broad range of infections, but regulatory agencies in the U.S. and Europe have added increasingly stark warnings to their labels over the past decade. Epidemiological studies have linked fluoroquinolone use to tendon rupture, peripheral neuropathy, and aortic aneurysm.34PubMed Central. Fluoroquinolone antibiotics and adverse events A systematic review and meta-analysis found that fluoroquinolone use more than doubled the risk of aortic aneurysm or aortic dissection within 60 days of exposure.35PubMed Central. Fluoroquinolones and the Risk of Aortic Aneurysm or Aortic Dissection: A Systematic Review and Meta-Analysis These remain appropriate drugs for serious infections where no safer alternative works. The concern is their routine prescription for minor infections like uncomplicated urinary tract infections or sinusitis, where narrower-spectrum antibiotics would be just as effective without the risk.
Nitrofurantoin, commonly prescribed to prevent recurrent urinary tract infections, is generally well tolerated in short courses. Long-term prophylactic use, however, has been associated with a list of serious adverse effects including pulmonary fibrosis, a form of irreversible scarring of the lung tissue. A case report documented severe fibrosis affecting multiple lobes of the lungs in a patient with a history of extended nitrofurantoin use, and the drug has also been linked in rare cases to aplastic anemia and liver toxicity.36PubMed Central. Nitrofurantoin-induced pulmonary fibrosis: a case report If you have been prescribed nitrofurantoin for long-term UTI prevention, your doctor should be monitoring your lung function and liver health periodically.
The Opioid-Benzodiazepine Combination
Taking an opioid painkiller and a benzodiazepine together is one of the most well-documented lethal drug combinations in modern medicine. Both classes of drug suppress breathing, and together they compound that effect dramatically. A review of 29 studies found that concurrent use increased the risk of death and severe respiratory events across most clinical and non-clinical settings examined.37PubMed. Combining opioids and benzodiazepines: effects on mortality and severe adverse respiratory events A large retrospective analysis put a specific number on the danger: people who used both drugs concurrently had more than double the risk of an opioid-overdose-related emergency room visit or hospitalization compared to those taking opioids alone.38BMJ. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis The FDA added a black-box warning to both drug classes in 2016, but the combination remains common, particularly in patients managing chronic pain alongside anxiety or insomnia. If you are prescribed both, the evidence strongly supports asking your prescriber whether one can be tapered or replaced.
Colchicine and the Danger of Narrow Margins
Colchicine, used for gout and certain inflammatory conditions, is an ancient drug derived from the autumn crocus. It is effective but has one of the narrowest therapeutic windows of any commonly prescribed medication: the difference between a dose that treats your gout flare and a dose that damages your organs is uncomfortably small. High fatality rates have been reported after acute ingestions exceeding 0.5 mg per kilogram of body weight, and the lowest reported lethal oral doses range from 7 to 26 mg, an amount that is not far above what a patient might accumulate through dosing errors or misunderstanding.39PubMed Central. Colchicine poisoning: the dark side of an ancient drug Colchicine poisoning leads to multi-organ failure, and because symptoms can be delayed by hours, patients sometimes continue taking additional doses before realizing anything is wrong. The drug remains useful and widely prescribed, but it demands careful dosing and awareness that “more” is genuinely dangerous in a way most people do not associate with a pill their doctor hands them for joint pain.